Ledger.Open graph →
SEC Form D · filed June 7, 2023

Biodexa Pharmaceuticals Plc

Offering
$3.3M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CARDIFF, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sijmen De Vries · Cardiff, United KingdomDirectorStephen Parker · Cardiff, United KingdomDirectorDmitry Zamoryakhin · Cardiff, United KingdomExecSimon Turton · Cardiff, United KingdomDirectorStephen Stamp · Cardiff, United KingdomExec · DirectorSanjay D. Nath · Mumbai, Maharashtra, K7ExecUmesh P. Salvi · Mumbai, Maharashtra, K7Exec · DirectorGreg Nobile · New York, NYDirectorJayesh B. Pandit · Mumbai, Maharashtra, K7DirectorAshish B. Fafadia · Mumbai, K7DirectorKatherine Eade · Morrisville, NCExecShankar Ramaswamy · Morrisville, NCDirectorBritt Petty · Morrisville, NCDirectorRoger Jeffs · Morrisville, NCExec · DirectorMatt Murphy · Boerne, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗